Research - Cambridge, England, United Kingdom
Spirea Limited is a Cambridge-based company created to advance a new generation of antibody-targeted cancer treatments with significantly better efficacy and safety profiles. Spirea will use its innovative technology to enable a pipeline of superior and differentiated antibody drug conjugates for the treatment of a range of solid tumours.
Outlook
Wix
Mobile Friendly
Google Cloud Hosting